[1] Chatterjee R , Mitra.A. An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer[J]. IntImmunopharmacol,2015,24(3):335 [2] Sun M. Kisseleva.reversibility of liver fibrosis[J]. Clin Res HepatolGastroenterol, 2015,(39):S60 [3] Frideman S L,Bansal M B. Reversal of hepatic fibrosis-fact of fantasy[J]. Hepatology, 2006,43(2 suppl 1):S82 [4] Hazem S H, Shaker M E, Ashamallah S A, et al. The novel Janus kinase inhibitor ruxolitinib confers protectionagainst carbon tetrachloride-induced hepatotoxicity viamultiplemechanisms[J]. ChemBiol Interact, 2014, 5(220):116 [5]杨凤蕊,娄建石,方步武. 蒿鳖养阴软坚方抗CCl4复合因素所致大鼠肝纤维化的作用[J]. 中草药, 2011,42(3):530 [6] 邢伟,孔维涵,方步武. 蒿鳖养阴软坚方对免疫性肝纤维化大鼠的治疗作用[J]. 中草药, 2010 (10): 1667 [7] 率红莉,方步武,邢伟,等. 蒿鳖养阴软坚方对四氯化碳复合因素所致肝纤维化的预防作用[J].中国实验方剂学杂志,2013, 19(16): 197 [8] 寇咏梅,刘洁莹,方步武. 蒿鳖养阴软坚方抗小鼠血吸虫病肝纤维化及其机制 的研究[J].现代药物与临床, 2013(3):288 [9] 冯硕,万永臻,张玉萍,等. 蒿鳖养阴软坚方给药大鼠体内乙醛含量的测定[J].现代中药研究与实践,2011,25(4):44 [10]HAN X Y, Hu J N, WANG Z, et al. 5-HMF attenuates liver fibrosis in CCl4-plus-alcohol-induced mice by suppression of oxidative stress[J].J NutrSciVitaminol, 2017,63(1):35 [11]XU J Y, SU Y Y, CHENG J S, et al. Hepatoprotective effects of fullerenol on carbon tetrachloride-induced acute hepatotoxicityand nephrotoxicity in rats [J]. Carbon, 2010, 48(5): 1388 [12] Shi F, Li X, Pan H, et al. .NQO1 and CYP450 reductase decrease the systemic exposure of rifampicin-quinone and mediate its redox cycle in rats[J]. J Pharm Biomed Anal, 2017,5(132):17 [13] Elaify M S, Adly A A, Attia A A,et al. Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in β-thalassemia major patients[J]. Hemoglobin, 2013,37(3):257 [14] Wu K C, Cui J Y, Klaassen C D. .Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transportersin mouse liver[J]. PLoS One, 2012,7(7):e39006 [15] Faig M, Bianchet M A, Winski S, et al. Structure-based development of anticancer drugs: complexes of NAD(P)H:quinoneoxidoreductase 1 with chemotherapeutic quinones[J]. Structure, 2001,9(8):659
[1]刘文东,李英娴,娄婷婷,等.青蒿琥酯对肝纤维化大鼠肝组织基质金属蛋白酶表达的影响[J].天津医科大学学报,2013,19(05):362.
[2]徐亚洁,张晓燕,马淑晶,等.神经酰胺对肝纤维化治疗作用的初步研究[J].天津医科大学学报,2014,20(04):260.
XU Ya-jie,ZHANG Xiao-yan,MA Shu-jing,et al.Effects of ceramide on hepatic fibrosis[J].Journal of Tianjin Medical University,2014,20(01):260.
[3]张晓燕,马淑晶,徐亚洁,等.青蒿琥酯对人源肝星状细胞LX-2增殖、胶原产生以及KLF6表达的影响[J].天津医科大学学报,2014,20(04):257.
ZHANG Xiao-yan,MA Shu-jing,XU Ya-jie,et al.Effects of artesunate on cell proliferation,collagen generated and KLF6 expression in hepatic stellate cells[J].Journal of Tianjin Medical University,2014,20(01):257.
[4]李萌乾,王青松,郭正隆,等.诱导型狨猴肝纤维化模型的建立 [J].天津医科大学学报,2014,20(06):433.
LI Meng-qian,WANG Qing-song,GUO Zheng-long,et al. Establishment of drug-induced common marmoset model for hepatic fibrosis[J].Journal of Tianjin Medical University,2014,20(01):433.
[5]卢娜,方步武.蒿鳖养阴软坚方对刀豆球蛋白A诱导的肝纤维化Nrf2/HO-1信号通路影响[J].天津医科大学学报,2018,24(02):112.
LU Na,FANG Bu-wu.Effect of Haobie yangyin ruanjian prescription on Nrf2/HO-1 signaling pathway in ConA-induced hepatic fibrosis[J].Journal of Tianjin Medical University,2018,24(01):112.
[6]张丽,方步武.虎杖苷抑制肝星状细胞增殖活化的作用和机制研究[J].天津医科大学学报,2020,26(04):309.
ZHANG Li,FANG Bu-wu.Inhibitory effects and mechanism of Polydatin on the proliferation and activation of hepatic stellate cell[J].Journal of Tianjin Medical University,2020,26(01):309.
[7]靳悦,汪河,李明威,等.CD24 通过调节肝内Ly6Clo 巨噬细胞亚群中PDGF-B 的
分泌抑制肝纤维化进程[J].天津医科大学学报,2022,28(03):260.
JIN Yue,WANG He,LI Ming-wei,et al.CD24 inhibits the liver fibrosis process by regulating the secretion of PDGF -B in hepatic Ly6Clo
macrophage subset[J].Journal of Tianjin Medical University,2022,28(01):260.
[8]刘志杰综述,詹江华审校.肝巨噬细胞在胆道闭锁肝纤维化中的作用[J].天津医科大学学报,2023,29(04):453.
[9]翁飞鸿,周一平,伊思敏,等.肝纤维化的病理学发生机制及诊疗研究进展[J].天津医科大学学报,2023,29(05):559.
[10]马立业,程欣欣,徐哲龙.p67phox在肝纤维化中的作用及其机制[J].天津医科大学学报,2024,30(06):514.[doi:10.20135/j.issn.1006-8147.2024.06.0514]
MA Liye,CHENG Xinxin,XU Zhelong.The role of p67phox in hepatic fibrosis and the underlying mechanism[J].Journal of Tianjin Medical University,2024,30(01):514.[doi:10.20135/j.issn.1006-8147.2024.06.0514]